It has been reported that the US Department of Health and Human Services has concluded its study on cannabis and is encouraging the Drug Enforcement Administration to relax the regulations of the Controlled Substances Act. This advice has brought about different considerations from governors, federal legislators, and large advocacy groups. Many are hopeful for the change proposed by the HHS, which could have major consequences for cannabis research and allow marijuana businesses to make federal tax deductions. However, some people don’t think the Schedule III classification goes far enough, since cannabis would still be considered illegal under federal law, which could have negative implications. It has been verified by both HHS and DEA that the letter was sent and has been received. Although there is vast enthusiasm surrounding the progression, the choice in regard to scheduling has yet to be fully confirmed. The Drug Enforcement Agency (DEA) has stated that it will review the results of the Food and Drug Administration’s (FDA) assessments, noting that it has the final power over the decision to classify the drug in Schedule III. Advocates, stakeholders, and government representatives from across the United States are sharing their considerations on the matter. This is what people are saying. Members of Congress Chuck Schumer, a Democrat from New York, is the Senate Majority Leader. Senator Schumer has asserted that the Department of Health and Human Services (HHS) has made a wise decision, and he has asked that the Drug Enforcement Agency (DEA) swiftly execute this meaningful action so as to substantially lessen the damage that strict cannabis regulations have caused.
To read the full article, click the link below: Read More